Published in Eur J Endocrinol on March 01, 1995
Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis. J Clin Endocrinol Metab (2014) 0.96
Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results. Br J Cancer (1999) 0.91
Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly. Pituitary (2012) 0.82
Somatostatin analogue treatment of neuroendocrine tumours. Postgrad Med J (1996) 0.77
Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol Cell Biol (1995) 3.02
The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes. Immunity (1996) 2.39
Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol (1994) 2.00
Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells. J Cell Biol (1996) 1.73
Brief report: heavy-chain deposition disease. N Engl J Med (1993) 1.63
Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J Biol Chem (1997) 1.52
Prevention of fatty streak formation of 17beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation (1997) 1.50
Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation (2001) 1.50
Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome. N Engl J Med (1992) 1.45
Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer (1993) 1.42
Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation (1998) 1.40
The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci U S A (2002) 1.38
Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res (2002) 1.29
Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer (2000) 1.26
Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide. J Clin Endocrinol Metab (1997) 1.26
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis (2001) 1.17
Potential oncogenic effects of basic fibroblast growth factor requires cooperation between CUG and AUG-initiated forms. Cell Regul (1991) 1.17
The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr (1972) 1.12
17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (1997) 1.10
Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium. J Clin Endocrinol Metab (1978) 1.06
Physicochemical and genetic evidence for specific antiestrogen binding sites. Proc Natl Acad Sci U S A (1983) 1.06
Possible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultured vascular endothelial cells. J Biol Chem (1986) 1.06
Detection of superoxide anion released extracellularly by endothelial cells using cytochrome c reduction, ESR, fluorescence and lucigenin-enhanced chemiluminescence techniques. Free Radic Biol Med (2000) 1.06
Alternative initiation of translation accounts for a 67/45 kDa dimorphism of the human estrogen receptor ERalpha. Biochem Biophys Res Commun (1999) 1.05
Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci U S A (1996) 1.04
Measurement of plasma aldosterone by radioimmunoassay. J Clin Endocrinol Metab (1970) 0.98
Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. Cancer Res (1995) 0.98
Plasma aldosterone concentration at delivery and during the newborn period. J Clin Invest (1972) 0.97
Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta. Cardiovasc Res (2001) 0.96
Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. Cancer Res (1987) 0.95
Role of fibroblast growth factor-2 isoforms in the effect of estradiol on endothelial cell migration and proliferation. Circ Res (2004) 0.94
Transplacental passage and fetal secretion of aldosterone. J Clin Invest (1970) 0.94
Autocrine regulation of bovine retinal capillary endothelial cell (BREC) proliferation by BREC-derived basic fibroblast growth factor. Exp Eye Res (1989) 0.93
Urinary iodine excretion during normal pregnancy in healthy women living in the southwest of France: correlation with maternal thyroid parameters. Thyroid (1997) 0.92
Detection and characterization of serum antitrichomonal antibodies in urogenital trichomoniasis. J Clin Microbiol (1985) 0.91
Synergies between regulatory elements of the immunoglobulin heavy chain locus and its palindromic 3' locus control region. Eur J Immunol (1998) 0.90
Pharmacokinetic profile of lanreotide Autogel in patients with acromegaly after four deep subcutaneous injections of 60, 90 or 120 mg every 28 days. Clin Endocrinol (Oxf) (2005) 0.90
The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res (1973) 0.89
Measurement of plasma 25-hydroxycholecalciferol in man. Eur J Clin Invest (1972) 0.89
Estrogens and atherosclerosis. Eur J Endocrinol (2004) 0.89
Phorbol esters induce both intracellular translocation and down-regulation of protein kinase C in MCF-7 cells. Biochem Biophys Res Commun (1986) 0.88
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab (2000) 0.87
Loss of atheroprotective effect of estradiol in immunodeficient mice. Endocrinology (2000) 0.87
Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide. J Clin Endocrinol Metab (1994) 0.87
Vasculoprotective effects of oestrogens. Clin Exp Pharmacol Physiol (2001) 0.87
Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clin Endocrinol (Oxf) (1994) 0.87
A dynamic study of plasma renin activity and aldosterone concentration in normal and hypertensive subjects. Metabolism (1971) 0.86
Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-acetate and 1,2-dioctanoyl-sn-glycerol: distinct effects on protein kinase C activity. Cancer Res (1988) 0.86
Transplacental passage of dexamethasone in sheep. J Endocrinol (1972) 0.86
Prevalence of thyroid abnormalities in patients with rheumatoid arthritis. Thyroidology (1992) 0.86
Appraisal of the double isotope dilution techniques for the measurement of plasma aldosterone. J Lab Clin Med (1970) 0.85
The regulation of aldosterone secretion in anephric man. J Clin Invest (1971) 0.85
Measurement of aldosterone secretion rate by radio-immunoassay. J Clin Endocrinol Metab (1970) 0.85
Purification, radioimmunoassay, and immunohistochemical localization of a glycoprotein produced by the rat epididymis. Biol Reprod (1980) 0.84
25-Hydroxycholecalciderol dynamics in human plasma. Rev Eur Etud Clin Biol (1972) 0.84
Opposite effects of tamoxifen on in vitro protein kinase C activity and endogenous protein phosphorylation in intact MCF-7 cells. Cancer Res (1990) 0.84
IRES-dependent regulation of FGF-2 mRNA translation in pathophysiological conditions in the mouse. Biochem Soc Trans (2006) 0.83
Multiple genomic defects result in an alternative RNA splice creating a human gamma H chain disease protein. J Immunol (1988) 0.83
The mitogenic effect of 17beta-estradiol on in vitro endothelial cell proliferation and on in vivo reendothelialization are both dependent on vascular endothelial growth factor. J Vasc Res (2000) 0.83
Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats. Endocrinology (1986) 0.83
Androgen receptors in the rat epididymis and their hormonal control. J Reprod Fertil (1979) 0.83
Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats. J Clin Invest (1993) 0.82
Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term tissue culture. Acta Endocrinol (Copenh) (1981) 0.82
Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum free conditions. Biochem Biophys Res Commun (1985) 0.82
Overexpression of the FGF-2 24-kDa isoform up-regulates IL-6 transcription in NIH-3T3 cells. FEBS Lett (1998) 0.82
[Sperm maturation. An acid protein of the rat epididymis. Androgen dependence, relationship with sialic acid]. C R Seances Soc Biol Fil (1973) 0.82
Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice. Atherosclerosis (2001) 0.81
Regulation of natriuretic peptide receptor A and B expression by transforming growth factor-beta 1 in cultured aortic smooth muscle cells. Hypertension (1994) 0.81
Antiestrogen specific, high affinity saturable binding sites in rat uterine cytosol. Biochem Biophys Res Commun (1980) 0.81
Arterio-venous transfer of testosterone in the spermatic cord of man. J Clin Endocrinol Metab (1975) 0.81
Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy. Diabetes Metab (1996) 0.81
An orthotopic aortic graft mouse model to study the immunopathology of chronic vascular rejection. Transplant Proc (2002) 0.81
Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells. Leukemia (1995) 0.81
Opposing effects of basic fibroblast growth factor and transforming growth factor-beta on the proliferation of cultured bovine retinal capillary endothelial (BREC) cells. Exp Eye Res (1989) 0.81
Effects of estrone on cell proliferation of a human breast cancer (MCF-7) in long term tissue culture. J Steroid Biochem (1979) 0.81
Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site. Biochem J (1998) 0.81
Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol. J Clin Endocrinol Metab (1977) 0.81
Testicular function in XYY men. Johns Hopkins Med J (1975) 0.81
Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). J Clin Endocrinol Metab (1996) 0.80
Role of inflammatory cytokines in the effect of estradiol on atheroma. Clin Exp Pharmacol Physiol (2008) 0.80
[Estradiol and progesterone receptors in human endometrium during the menstrual cycle]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.80
Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc Res (1999) 0.80
Long term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly. J Clin Endocrinol Metab (1989) 0.80
Androgen interaction with the oestrogen receptor in human tissues. J Steroid Biochem (1980) 0.80
Estrogen and progestin regulation of the progesterone receptor concentration in human endometrium. J Clin Endocrinol Metab (1979) 0.80
Plasma androgens and LH in scoliotic patients with premature pubarche. J Clin Endocrinol Metab (1974) 0.79
Variable growth hormone profiles following withdrawal of long-term 30mg slow-release lanreotide treatment in acromegalic patients: clinical implications. Eur J Endocrinol (2000) 0.79
Tumor necrosis factor-alpha inhibits follicle-stimulating hormone-induced differentiation in cultured rat granulosa cells. Biochem Biophys Res Commun (1989) 0.79
[Effects of biliary lithogenesis in acromegalic patients with long-term octreotide (SMS 201-995) treatment]. Gastroenterol Clin Biol (1991) 0.79
Transcriptional regulation of hydroxyindole O-methyltransferase in the chicken pineal gland: day/night changes and long-term effects of light and darkness. Biochem J (1993) 0.79
The atheroprotective effect of 17 beta-estradiol is not altered in P-selectin- or ICAM-1-deficient hypercholesterolemic mice. Atherosclerosis (2003) 0.79
Phorbol esters inhibit the proliferation of MCF-7 cells. Possible implication of protein kinase C. Biochem Pharmacol (1986) 0.79
Localization of mRNA coding for the three subtypes of atrial natriuretic factor (ANF) receptors in rat anterior pituitary gland cells. J Neuroendocrinol (1995) 0.79
Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity. Biochem Pharmacol (1999) 0.78
Plasma 25-hydroxycholecalciferol in chronic renal failure. Eur J Clin Invest (1973) 0.78
Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide. Eur J Endocrinol (1994) 0.78
Adaptation of the human breast cancer cell line MCF-7 to serum free medium culture on extracellular matrix. Biochem Biophys Res Commun (1982) 0.78
Further evidence for a biological role of anti-estrogen-binding sites in mediating the growth inhibitory action of diphenylmethane derivatives. Chem Biol Interact (1988) 0.78